A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity

BACKGROUND: Clinical benefit from checkpoint inhibitors has been associated in a tumor-agnostic manner with two main tumor traits. The first is tumor antigenicity, which is typically measured by tumor mutation burden, microsatellite instability (MSI), or Mismatch Repair Deficiency using gene sequenc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Immunother Cancer
Asıl Yazarlar: Danaher, Patrick, Warren, Sarah, Ong, SuFey, Elliott, Nathan, Cesano, Alessandra, Ferree, Sean
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6341623/
https://ncbi.nlm.nih.gov/pubmed/30665466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0472-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller